Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...

9 analysts have shared their evaluations of Abbott Laboratories (NYSE:ABT) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

An announcement from Abbott Laboratories ( ($ABT) ) is now available. On December 12, 2025, Abbott Laboratories announced the ...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective upped by equities research analysts at Morgan Stanley from $117.00 to $127.00 in a note issued to investors on ...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by analysts at Jefferies Financial Group from $135.00 to $137.00 in a research note issued on Thursday,Benzinga reports.

A more conservative goal of $100 monthly dividend income would require 508 shares of Abbott. An investor would need to own $325,274 worth of Abbott Laboratories to generate a monthly dividend income ...

Disclosed on November 25, Eric Shroff, Senior Vice President at Abbott Laboratories (NYSE:ABT), executed a substantial insider sell as per the latest SEC filing. What Happened: Shroff's decision to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...